Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Print Print
Recommend this article Recommend this article
Save as favorites Save as favorites
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates


Journal of the American Academy of Dermatology
Volume 52, n° 3S
page P1 (mars 2005)
Doi : 10.1016/j.jaad.2004.10.018
Comparison of biologic therapies for the treatment of psoriasis
 

William Abramovits, MD, Texas Dermatology Research Institute, Dallas, TX, United States; Lisa Stevenson, BA, MS II


 P2
William Abramovits, MD, has received research support and/or is a consultant and/or lecturer for the following: Abbott Laboratories, Allergan, Inc., Amgen, Inc., Astralis, Inc., Berlex, Inc., Biogen Idec, Bradley Pharmaceuticals, Brymill Cryogenics, Centocor, Inc., Collagenex Pharmaceuticals
Connetics Corporation, Corixa Corporation, Dermik Laboratories, Doak Dermatologics Ferndale Laboratories, Inc., Fujisawa Healthcare, Inc., Galderma, Genentech, Inc.
GlaxoSmithKline, IDEC Corporation, Ligand Pharmaceuticals, Medicis, MedImmune, Inc.
Novartis Pharmaceuticals, Otsuka Pharmaceutical, Inc., Protein Design Labs, Serono Synta Pharma, and 3M Pharmaceuticals.


Top of the page

© 2005  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
Start of article
@@#110903@@